JP2025010535A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025010535A5 JP2025010535A5 JP2024155192A JP2024155192A JP2025010535A5 JP 2025010535 A5 JP2025010535 A5 JP 2025010535A5 JP 2024155192 A JP2024155192 A JP 2024155192A JP 2024155192 A JP2024155192 A JP 2024155192A JP 2025010535 A5 JP2025010535 A5 JP 2025010535A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage
- pharmaceutical composition
- amlodipine besylate
- indapamide
- telmisartan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762450324P | 2017-01-25 | 2017-01-25 | |
| US62/450,324 | 2017-01-25 | ||
| JP2019539974A JP2020506180A (ja) | 2017-01-25 | 2018-01-23 | 高血圧症の処置のための組成物 |
| PCT/IB2018/000083 WO2018138578A1 (en) | 2017-01-25 | 2018-01-23 | Compositions for the treatment of hypertension |
| JP2022199757A JP2023063282A (ja) | 2017-01-25 | 2022-12-14 | 高血圧症の処置のための組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199757A Division JP2023063282A (ja) | 2017-01-25 | 2022-12-14 | 高血圧症の処置のための組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025010535A JP2025010535A (ja) | 2025-01-21 |
| JP2025010535A5 true JP2025010535A5 (enExample) | 2025-07-09 |
Family
ID=62979058
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539974A Pending JP2020506180A (ja) | 2017-01-25 | 2018-01-23 | 高血圧症の処置のための組成物 |
| JP2022199757A Pending JP2023063282A (ja) | 2017-01-25 | 2022-12-14 | 高血圧症の処置のための組成物 |
| JP2024155192A Pending JP2025010535A (ja) | 2017-01-25 | 2024-09-09 | 高血圧症の処置のための組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539974A Pending JP2020506180A (ja) | 2017-01-25 | 2018-01-23 | 高血圧症の処置のための組成物 |
| JP2022199757A Pending JP2023063282A (ja) | 2017-01-25 | 2022-12-14 | 高血圧症の処置のための組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (7) | US10322117B2 (enExample) |
| EP (6) | EP4620524A3 (enExample) |
| JP (3) | JP2020506180A (enExample) |
| KR (4) | KR20240096848A (enExample) |
| CN (4) | CN120585831A (enExample) |
| AU (3) | AU2018213147B2 (enExample) |
| CA (1) | CA3051374A1 (enExample) |
| DK (2) | DK4101454T3 (enExample) |
| ES (2) | ES2981657T3 (enExample) |
| FI (2) | FI3573620T3 (enExample) |
| HR (2) | HRP20230267T1 (enExample) |
| HU (2) | HUE067617T2 (enExample) |
| LT (2) | LT3573620T (enExample) |
| MX (2) | MX2019008813A (enExample) |
| PL (2) | PL4101454T3 (enExample) |
| PT (2) | PT4101454T (enExample) |
| RS (2) | RS64042B1 (enExample) |
| RU (1) | RU2019126749A (enExample) |
| SI (2) | SI3573620T1 (enExample) |
| TW (5) | TW202508572A (enExample) |
| WO (1) | WO2018138578A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
| DK4101454T3 (da) | 2017-01-25 | 2024-06-17 | The George Inst For Global Health | Sammensætninger til behandling af hypertension |
| US12521380B2 (en) | 2017-01-25 | 2026-01-13 | The George Institute for Global Health | Compositions for the treatment of hypertension |
| WO2020041864A1 (en) * | 2018-08-25 | 2020-03-05 | Crd Pharmaceuticals Inc. | Synchronize hypertensive therapy with circadian rhythm |
| CN111789843A (zh) | 2019-04-08 | 2020-10-20 | 深圳奥萨医药有限公司 | 含氨氯地平、氯噻酮和阿米洛利的药物组合物 |
| CN113616651B (zh) * | 2020-05-08 | 2023-12-29 | 深圳奥萨制药有限公司 | 一种复方降压药物组合物及其应用 |
| US11730706B1 (en) * | 2022-07-07 | 2023-08-22 | Antecip Bioventures Ii Llc | Treatment of depression in certain patient populations |
| EP4574148A1 (en) | 2023-12-20 | 2025-06-25 | KRKA, d.d., Novo mesto | Fixed combination of telmisartan, amlodipine and indapamide for the treatment of hypertension |
| WO2025226012A1 (ko) | 2024-04-23 | 2025-10-30 | 신풍제약주식회사 | 칸데사르탄, 암로디핀 및 인다파미드를 포함하는 고혈압 예방 또는 치료용 약제학적 복합제제 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT199800126A (es) | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
| GB2361185A (en) | 2000-04-10 | 2001-10-17 | Nicholas J Wald | Pharmaceutical formulation for the prevention of cardiovascular disease |
| ATE326240T2 (de) | 2000-04-10 | 2006-06-15 | Nicholas John Wald | Zusammensetzung zur prävention kardiovaskulärer erkrankungen |
| EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
| US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
| US20050209288A1 (en) * | 2004-01-12 | 2005-09-22 | Grogan Donna R | Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use |
| US20070191438A1 (en) | 2004-04-06 | 2007-08-16 | Rohrer Susan P | Methods for the treatment of hypertension |
| KR100582347B1 (ko) | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| US20070196510A1 (en) | 2006-02-17 | 2007-08-23 | Gerber Michael J | Method for treating resistant hypertension |
| ES2388555T3 (es) | 2006-03-16 | 2012-10-16 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona |
| US20070293552A1 (en) | 2006-06-15 | 2007-12-20 | Gorczynski Richard J | Antihypertensive therapy method |
| EP2545920A1 (en) | 2007-08-22 | 2013-01-16 | Abbott GmbH & Co. KG | Therapy for complications of diabetes |
| KR20090057538A (ko) * | 2007-12-03 | 2009-06-08 | 박사룡 | 안지오텐신 투 안타고니스트, 칼슘 안타고니스트 및이뇨제를 함유하는 고혈압 치료제 조성물 |
| CN101450211A (zh) * | 2007-12-07 | 2009-06-10 | 上海艾力斯医药科技有限公司 | 复方降压制剂 |
| DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| CN101966187A (zh) * | 2009-07-14 | 2011-02-09 | 邬林祥 | 一种治疗高血压含氨氯地平和厄贝沙坦的复方制剂 |
| CN101618215A (zh) | 2009-08-16 | 2010-01-06 | 王丽燕 | 含钙拮抗剂、aⅱ受体拮抗剂和他汀类药的药物组合物 |
| KR20130061148A (ko) | 2010-05-03 | 2013-06-10 | 티에스에이치 바이오팜 코포레이션 리미티드 | 고혈압 치료용 약학 조성물 및 방법 |
| EP2575808A1 (en) * | 2010-05-28 | 2013-04-10 | Mahmut Bilgic | Combination of antihypertensive agents |
| CN101966190A (zh) * | 2010-07-17 | 2011-02-09 | 邬林祥 | 一种治疗高血压含氨氯地平和依普罗沙坦的复方制剂 |
| CN102225203A (zh) * | 2011-06-29 | 2011-10-26 | 北京阜康仁生物制药科技有限公司 | 一种用于降低血压的药用组合物 |
| CN102327272B (zh) | 2011-07-14 | 2013-08-14 | 海南锦瑞制药股份有限公司 | 一种口服固体药用组合物及其制备方法 |
| US10918612B2 (en) * | 2013-01-22 | 2021-02-16 | Markus Zwickl | Combinations with 2-aminoethanesulfonic acid |
| US9839644B2 (en) * | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
| CZ2015687A3 (cs) | 2015-10-02 | 2017-04-12 | Zentiva, K.S. | Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu |
| CN106074418A (zh) | 2016-06-23 | 2016-11-09 | 南京华宽信息咨询中心 | 一种治疗高血压的苯磺酸氨氯地平片及其制备方法 |
| CN106310278A (zh) * | 2016-08-01 | 2017-01-11 | 深圳奥萨制药有限公司 | 一种含叶酸的多联降压药物组合物 |
| US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
| US12521380B2 (en) | 2017-01-25 | 2026-01-13 | The George Institute for Global Health | Compositions for the treatment of hypertension |
| DK4101454T3 (da) | 2017-01-25 | 2024-06-17 | The George Inst For Global Health | Sammensætninger til behandling af hypertension |
| KR20210038931A (ko) * | 2018-07-26 | 2021-04-08 | 더 조지 인스티튜트 포 글로벌 헬스 | 고혈압 치료용 조성물 |
-
2018
- 2018-01-23 DK DK22188172.5T patent/DK4101454T3/da active
- 2018-01-23 DK DK18745362.6T patent/DK3573620T3/da active
- 2018-01-23 EP EP25186476.5A patent/EP4620524A3/en active Pending
- 2018-01-23 HU HUE22188172A patent/HUE067617T2/hu unknown
- 2018-01-23 KR KR1020247019312A patent/KR20240096848A/ko not_active Ceased
- 2018-01-23 AU AU2018213147A patent/AU2018213147B2/en active Active
- 2018-01-23 CA CA3051374A patent/CA3051374A1/en active Pending
- 2018-01-23 PL PL22188172.5T patent/PL4101454T3/pl unknown
- 2018-01-23 CN CN202510891838.2A patent/CN120585831A/zh active Pending
- 2018-01-23 CN CN202310463571.8A patent/CN116327958A/zh active Pending
- 2018-01-23 HR HRP20230267TT patent/HRP20230267T1/hr unknown
- 2018-01-23 FI FIEP18745362.6T patent/FI3573620T3/fi active
- 2018-01-23 KR KR1020257021924A patent/KR20250107955A/ko active Pending
- 2018-01-23 EP EP25191988.2A patent/EP4635566A3/en active Pending
- 2018-01-23 ES ES22188172T patent/ES2981657T3/es active Active
- 2018-01-23 CN CN202411603186.XA patent/CN119386015A/zh active Pending
- 2018-01-23 RU RU2019126749A patent/RU2019126749A/ru unknown
- 2018-01-23 LT LTEPPCT/IB2018/000083T patent/LT3573620T/lt unknown
- 2018-01-23 WO PCT/IB2018/000083 patent/WO2018138578A1/en not_active Ceased
- 2018-01-23 KR KR1020197024682A patent/KR20190127691A/ko not_active Ceased
- 2018-01-23 RS RS20230204A patent/RS64042B1/sr unknown
- 2018-01-23 PL PL18745362.6T patent/PL3573620T3/pl unknown
- 2018-01-23 ES ES18745362T patent/ES2940316T3/es active Active
- 2018-01-23 EP EP24164449.1A patent/EP4374915A3/en active Pending
- 2018-01-23 JP JP2019539974A patent/JP2020506180A/ja active Pending
- 2018-01-23 EP EP18745362.6A patent/EP3573620B1/en active Active
- 2018-01-23 FI FIEP22188172.5T patent/FI4101454T3/fi active
- 2018-01-23 SI SI201830873T patent/SI3573620T1/sl unknown
- 2018-01-23 CN CN201880021071.6A patent/CN110545819A/zh active Pending
- 2018-01-23 SI SI201831107T patent/SI4101454T1/sl unknown
- 2018-01-23 LT LTEP22188172.5T patent/LT4101454T/lt unknown
- 2018-01-23 HR HRP20240701TT patent/HRP20240701T1/hr unknown
- 2018-01-23 HU HUE18745362A patent/HUE061444T2/hu unknown
- 2018-01-23 RS RS20240644A patent/RS65701B1/sr unknown
- 2018-01-23 MX MX2019008813A patent/MX2019008813A/es unknown
- 2018-01-23 EP EP25190561.8A patent/EP4609913A3/en active Pending
- 2018-01-23 EP EP22188172.5A patent/EP4101454B1/en active Active
- 2018-01-23 PT PT221881725T patent/PT4101454T/pt unknown
- 2018-01-23 KR KR1020257011127A patent/KR20250052479A/ko not_active Ceased
- 2018-01-23 PT PT187453626T patent/PT3573620T/pt unknown
- 2018-01-25 TW TW113126576A patent/TW202508572A/zh unknown
- 2018-01-25 TW TW112101171A patent/TWI852279B/zh active
- 2018-01-25 TW TW109105655A patent/TWI825279B/zh active
- 2018-01-25 TW TW112142923A patent/TW202421198A/zh unknown
- 2018-01-25 TW TW107102631A patent/TW201831204A/zh unknown
- 2018-03-13 US US15/919,923 patent/US10322117B2/en active Active
-
2019
- 2019-04-24 US US16/393,774 patent/US10799487B2/en active Active
- 2019-07-24 MX MX2023004366A patent/MX2023004366A/es unknown
-
2020
- 2020-09-08 US US17/014,358 patent/US11478462B2/en active Active
-
2022
- 2022-09-16 US US17/932,982 patent/US12102623B2/en active Active
- 2022-12-14 JP JP2022199757A patent/JP2023063282A/ja active Pending
-
2023
- 2023-08-08 US US18/446,268 patent/US12285415B2/en active Active
- 2023-11-27 AU AU2023274064A patent/AU2023274064B2/en active Active
-
2024
- 2024-09-09 JP JP2024155192A patent/JP2025010535A/ja active Pending
-
2025
- 2025-04-01 US US19/097,314 patent/US12465599B2/en active Active
- 2025-09-26 US US19/341,633 patent/US20260027093A1/en active Pending
- 2025-12-31 AU AU2025287416A patent/AU2025287416A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5264446A (en) | Solid medicament formulations containing nifedipine, and processes for their preparation | |
| US4066756A (en) | Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin | |
| JP3759624B2 (ja) | 偏頭痛の改良治療 | |
| JP5658172B2 (ja) | アムロジピン及びロサルタンを含む固形薬剤学的組成物及びその製造方法 | |
| RU99107283A (ru) | Не содержащие лактозы, негигроскопичные и безводные фармацевтические препараты дескарбоэтоксилоратадина | |
| GB2105193A (en) | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents | |
| PT969836E (pt) | Composições farmacêuticas anidras e não higroscópicas de descarboetoxiloratadina isentas de lactose | |
| RU2009127302A (ru) | Способ изготовления твердого, орально применимого фармацевтического состава | |
| RU2010144131A (ru) | Капсула и лекарственное средство для профилактики сердечно-сосудистых заболеваний | |
| FI4101454T3 (fi) | Koostumuksia käytettäviksi kohonneen verenpaineen hoitoon | |
| JPH05246853A (ja) | 医 薬 | |
| RU2004132205A (ru) | Комбинации эпинастина, белладонны и псевдоэфедрина в качестве новых фармацевтических составов | |
| CN201257161Y (zh) | 复方单硝酸异山梨酯双释胶囊 | |
| JPH0276815A (ja) | 医薬 | |
| JPH0296525A (ja) | 医薬 | |
| ES2811904T3 (es) | Composición farmacéutica que comprende bisoprolol y perindopril | |
| CN101756981B (zh) | 一种布洛氯雷伪麻缓释制剂及其制备方法 | |
| CN101897709A (zh) | 含有小剂量叶酸和阿司匹林的药物组合物及其用途 | |
| GB2216413A (en) | Medicaments containing sufotidine | |
| CN108553416A (zh) | 一种含有左旋多巴和盐酸苄丝肼的缓释混悬制剂及其制备方法 | |
| JP2573969B2 (ja) | 薬物断続放出性口腔内適用製剤 | |
| JPS5865215A (ja) | 医薬組成物 | |
| CN101590235A (zh) | 含有钙拮抗剂和b族维生素的组合物及其用途 | |
| JPS5855421A (ja) | 医薬組成物 | |
| CN101596158B (zh) | 一种对乙酰氨基酚、伪麻黄碱和右美沙芬的复方缓释制剂 |